Literature DB >> 32941016

Catalytic Asymmetric Synthesis of Chiral Covalent Organic Frameworks from Prochiral Monomers for Heterogeneous Asymmetric Catalysis.

Jian-Cheng Wang1, Xuan Kan1, Jin-Yan Shang1, Hua Qiao1, Yu-Bin Dong1.   

Abstract

Direct synthesis, postsynthetic modification, and chiral induction have been recognized as three powerful methods to synthesize chiral covalent organic frameworks (CCOFs). However, catalytic asymmetric methodology, as the most important and effective synthetic approach to access chiral organics, has not been enabled for CCOFs synthesis thus far. Herein we report, for the first time, the construction of CCOFs from prochiral monomers via catalytic asymmetric polymerization. The obtained propargylamine-linked CCOFs can be the highly reusable chiral catalysts to promote asymmetric Michael addition reactions. The concept of catalytic asymmetric polymerization might open a new route for constructing the CCOFs that are not possible with the existing CCOF synthetic methods.

Entities:  

Year:  2020        PMID: 32941016     DOI: 10.1021/jacs.0c07461

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  3 in total

1.  Ambient synthesis of an iminium-linked covalent organic framework for synergetic RNA interference and metabolic therapy of fibrosarcoma.

Authors:  Le-Le Zhou; Qun Guan; Wei Zhou; Jing-Lan Kan; Yu-Bin Dong
Journal:  Chem Sci       Date:  2022-06-15       Impact factor: 9.969

2.  A BINOL-phosphoric acid and metalloporphyrin derived chiral covalent organic framework for enantioselective α-benzylation of aldehydes.

Authors:  Hui-Chao Ma; Ya-Nan Sun; Gong-Jun Chen; Yu-Bin Dong
Journal:  Chem Sci       Date:  2022-01-14       Impact factor: 9.825

Review 3.  Challenges and opportunities for chiral covalent organic frameworks.

Authors:  Xing Kang; Emily R Stephens; Benjamin M Spector-Watts; Ziping Li; Yan Liu; Lujia Liu; Yong Cui
Journal:  Chem Sci       Date:  2022-07-20       Impact factor: 9.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.